tiprankstipranks
MustGrow Biologics (TSE:MGRO)
:MGRO
Canadian Market
MGRO
MustGrow Biologics
RESEARCH TOOLSreports
Want to see TSE:MGRO full AI Analyst Report?

MustGrow Biologics (MGRO) Ratios

19 Followers

MustGrow Biologics Ratios

TSE:MGRO's free cash flow for Q4 2025 was C$0.15. For the 2025 fiscal year, TSE:MGRO's free cash flow was decreased by C$ and operating cash flow was C$-1.60. See a summary of the company’s cash flow.
Ratios
TTM
Dec 25Mar 25Mar 24Mar 23
Liquidity Ratios
Current Ratio
 1.48 1.48 1.61 5.72 4.63
Quick Ratio
 0.51 0.51 1.12 5.72 4.63
Cash Ratio
 0.44 0.44 1.03 5.62 4.56
Solvency Ratio
 -3.24 -3.24 -1.58 -0.50 -2.94
Operating Cash Flow Ratio
 -2.44 -2.44 -1.24 -0.24 -2.11
Short-Term Operating Cash Flow Coverage
 -11.69 -11.69 -9.09 -0.48 -8.06
Net Current Asset Value
C$ 834.49KC$ 834.49KC$ 1.41MC$ 5.58MC$ 5.24M
Leverage Ratios
Debt-to-Assets Ratio
 0.19 0.19 0.10 0.11 0.11
Debt-to-Equity Ratio
 0.67 0.67 0.24 0.14 0.14
Debt-to-Capital Ratio
 0.40 0.40 0.19 0.12 0.13
Long-Term Debt-to-Capital Ratio
 0.13 0.13 0.05 0.02 0.06
Financial Leverage Ratio
 3.57 3.57 2.50 1.24 1.36
Debt Service Coverage Ratio
 -9.28 -8.31 -13.00 -1.09 -13.41
Interest Coverage Ratio
 -24.51 -19.97 0.00 0.00 -551.93
Debt to Market Cap
 0.02 0.02 <0.01 0.01 <0.01
Interest Debt Per Share
 0.01 0.02 0.01 0.02 0.02
Net Debt to EBITDA
 0.05 0.05 0.48 8.95 1.13
Profitability Margins
Gross Profit Margin
17.33%17.03%75.56%91.84%100.00%
EBIT Margin
-77.68%-75.45%-1228.27%-14.37%-85750.50%
EBITDA Margin
-77.06%-74.84%-1284.91%-14.37%-85750.50%
Operating Profit Margin
-75.45%-75.45%-1284.91%-17.08%-85750.50%
Pretax Profit Margin
-87.58%-87.58%-1228.27%-14.37%-85905.87%
Net Profit Margin
-87.58%-87.58%-1228.27%-14.37%-85905.87%
Continuous Operations Profit Margin
-87.58%-87.58%-1228.27%-14.37%-85905.87%
Net Income Per EBT
100.00%100.00%100.00%100.00%100.00%
EBT Per EBIT
116.07%116.07%95.59%84.09%100.18%
Return on Assets (ROA)
-234.64%-234.64%-90.26%-9.76%-78.01%
Return on Equity (ROE)
-684.94%-837.00%-225.33%-12.12%-106.24%
Return on Capital Employed (ROCE)
-613.93%-613.93%-202.97%-14.06%-99.31%
Return on Invested Capital (ROIC)
-430.85%-430.85%-175.56%-12.69%-92.62%
Return on Tangible Assets
-234.64%-234.64%-100.99%-9.76%-78.01%
Earnings Yield
-21.63%-21.19%-8.24%-1.05%-3.21%
Efficiency Ratios
Receivables Turnover
 119.61 119.61 3.87 49.70 0.07
Payables Turnover
 4.17 4.19 0.04 1.20 0.00
Inventory Turnover
 3.43 3.44 0.07 0.00 0.00
Fixed Asset Turnover
 254.09 254.09 2.21 0.00 0.00
Asset Turnover
 2.68 2.68 0.07 0.68 <0.01
Working Capital Turnover Ratio
 4.53 6.03 0.11 0.83 <0.01
Cash Conversion Cycle
 22.08 22.01 -3.93K -297.94 4.95K
Days of Sales Outstanding
 3.05 3.05 94.25 7.34 4.95K
Days of Inventory Outstanding
 106.50 106.13 5.37K 0.00 0.00
Days of Payables Outstanding
 87.48 87.17 9.39K 305.29 0.00
Operating Cycle
 109.55 109.18 5.46K 7.34 4.95K
Cash Flow Ratios
Operating Cash Flow Per Share
 -0.09 -0.09 -0.07 >-0.01 -0.07
Free Cash Flow Per Share
 -0.11 -0.12 -0.07 >-0.01 -0.07
CapEx Per Share
 0.03 0.03 <0.01 <0.01 0.00
Free Cash Flow to Operating Cash Flow
 1.30 1.30 1.00 1.00 1.00
Dividend Paid and CapEx Coverage Ratio
 -3.35 -3.37 -894.57K -73.69K 0.00
Capital Expenditure Coverage Ratio
 -3.35 -3.37 -894.57K -73.69K 0.00
Operating Cash Flow Coverage Ratio
 -8.66 -8.66 -6.91 -0.39 -4.29
Operating Cash Flow to Sales Ratio
 -0.61 -0.61 -8.99 -0.06 -502.78
Free Cash Flow Yield
-19.58%-19.15%-6.03%-0.46%-1.88%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
 -4.62 -4.72 -12.14 -95.08 -31.17
Price-to-Sales (P/S) Ratio
 4.05 4.13 149.08 13.66 26.78K
Price-to-Book (P/B) Ratio
 38.69 39.49 27.35 11.53 33.12
Price-to-Free Cash Flow (P/FCF) Ratio
 -5.11 -5.22 -16.58 -218.36 -53.26
Price-to-Operating Cash Flow Ratio
 -6.63 -6.77 -16.58 -218.36 -53.26
Price-to-Earnings Growth (PEG) Ratio
 0.15 -0.13 -0.02 1.08 -0.55
Price-to-Fair Value
 38.69 39.49 27.35 11.53 33.12
Enterprise Value Multiple
 -5.20 -5.47 -11.12 -86.13 -30.10
Enterprise Value
 33.21M 33.91M 56.86M 58.31M 167.24M
EV to EBITDA
 -5.20 -5.47 -11.12 -86.13 -30.10
EV to Sales
 4.01 4.09 142.85 12.37 25.81K
EV to Free Cash Flow
 -5.06 -5.17 -15.89 -197.81 -51.34
EV to Operating Cash Flow
 -6.57 -6.70 -15.89 -197.81 -51.34
Tangible Book Value Per Share
 0.01 0.02 0.03 0.11 0.11
Shareholders’ Equity Per Share
 0.01 0.02 0.04 0.11 0.11
Tax and Other Ratios
Effective Tax Rate
 0.00 0.00 0.00 0.00 0.00
Revenue Per Share
 0.14 0.15 <0.01 0.09 <0.01
Net Income Per Share
 -0.12 -0.13 -0.09 -0.01 -0.11
Tax Burden
 1.00 1.00 1.00 1.00 1.00
Interest Burden
 1.13 1.16 1.00 1.00 1.00
Research & Development to Revenue
 0.06 0.06 1.94 0.18 73.45
SG&A to Revenue
 0.77 0.87 9.60 0.66 697.47
Stock-Based Compensation to Revenue
 0.16 0.00 3.70 0.29 261.54
Income Quality
 0.70 0.70 0.73 0.44 0.59
Currency in CAD